Response Genetics (RGDX) Reports Q4 Loss of $0.09/Share
Tweet
Share
E-mailGet Alerts RGDX Hot Sheet
Join SI Premium – FREE
Response Genetics (NASDAQ: RGDX) reported Q4 EPS of ($0.09), versus ($0.06) reported last year. Revenue for the quarter came in at $4.1 million, versus $4.8 million reported last year.
For earnings history and earnings-related data on Response Genetics (RGDX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Nike (NKE) Tops Q1 EPS by 4c
- Brady sells French first-aid unit Securimed for ~$59 million
- Pentair completes $1.4B acquisition of Taco Group Holdings
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
